# Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

> **NCT01957878** · PHASE2 · COMPLETED · sponsor: **Genticel** · enrollment: 239 (actual)

## Conditions studied

- Genital Infection Viral
- HUMAN PAPILLOMA VIRUS

## Interventions

- **BIOLOGICAL:** ProCervix
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01957878
- **Lead sponsor:** Genticel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01957878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01957878, "Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01957878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*